← Evidence map

ArticleTherapeutic advances in hematology2025

Ibrutinib oral suspension bioavailability and compatibility for optimal enteral administration route.

Jonas Paludo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41467123